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Objective
To analyze clinical characteristics and growth develop-
ment of 153 disorders of sex development (DSD) and
non-CAH patients.
Method
To collect DSD patients’ clinical data, including age, gen-
der and family history. To definite categories and assess
height, weight and measure penis length and testis volume
and describe the deformation. Determine the levels of sex
hormones. HCG test, B ultrasonic and chromosomes were
performed.
Result
Chief complain of all these patients to see doctors were
abnormal external genitalia. I53 DSD patients include
social sex 128 male and 25 female from 42 days to16y10m
(4.59±4.25y). There were 121 (90.3%) 46XYDSD. 39 cases
(32.2%) were diagnosed as hypospadias combined with
micropenis, 19(15.7%) were micropenis with testis
abnormality and 18 cases(14.9%) were simple micropenis.
13(10.7%) were testis abnormality, 9(7.4%) were hypospa-
dias, 1 (0.8%) were hypospadias combined with testis
abnormality, micropenis combined with hypospadias and
testis abnormality were 14(11.6%). 15 (9.8%) cases had
DSD family histories and 19 (12.4%) patients’ mother had
taken progesterone when early pregnant stage threatened
abortion. With face/limbs malformation or mental pro-
blems were 17 (11.1%) . Most of DSD were shorter than
the normal population, 16 (10.4%) was <-2SDS, 115
(75.2%)<1SDS. The proportion of height shorter than 25
percentile and 50 percentile was more than normal popu-
lation, P=0.039 and 0.056 respectively. There were
40 cases with testis abnormality DSD, whose height were
shorter than normal population (P=0.041and 0.015). 130/
153 DSD were performed HCG test, height>P50 was
60.3% among 78 who had normal testorone respond,
while only 18.2% height>P50 among 33 cases with abnor-
mal testorone respond (P=0.000).
Conclusion
This non-CAH DSD included 46XYDSD (121 cases),
46XXDSD (3 cases) and chromosome DSD(10 cases).
The most number of 46XYDSD was hypospadias com-
bined with micropenis, the second was micropenis.
Some patients had DSD family histories and some
patients whose mother had been threatened abortion
and progesterone exposure duration pregnancy. DSD
may have malformation of face/limbs or internal organs
or mental problems. Patients with DSD may have both
disorders of sex development and short statures. Most
of DSD were shorter than normal population and testi-
cular development was related to short statures. So
when we evaluated DSD, not only should pay attention
to sex development but also to short statures.
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